Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease

Xiaowen Zheng , Feng Chen , Qian Zhang , Yulan Liu , Peng You , Shan Sun , Jiuxiang Lin , Ning Chen

Protein Cell ›› 2017, Vol. 8 ›› Issue (9) : 686 -695.

PDF (879KB)
Protein Cell ›› 2017, Vol. 8 ›› Issue (9) : 686 -695. DOI: 10.1007/s13238-017-0413-7
RESEARCH ARTICLE
RESEARCH ARTICLE

Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease

Author information +
History +
PDF (879KB)

Abstract

Inflammatory bowel disease (IBD) is an intestinal immune-dysfunctional disease worldwide whose prevalence increasing in Asia including China. It is a chronic disease of the gastrointestinal tract with unknown cause. Exosomes are small vesicles in various body fluids. They have diameters of 40–120 nm, and one of their functions is long-distance transfer of various substances. In this study, we investigated the contents of salivary exosomes in patients with IBD and in healthy controls to explore a new biomarker in patients with IBD. In this study, whole saliva was obtained from patients with IBD (ulcerative colitis (UC), n= 37; Crohn’s disease (CD), n= 11) and apparently healthy individuals (HC, n= 10). Salivary exosomes were extracted from samples, and the proteins within the exosomes were identified by liquid chromatograph-mass spectrometer (LCMS/MS). The results showed that more than 2000 proteins were detected in salivary exosomes from patients with IBD. Through gene ontology analysis, we found that proteasome subunit alpha type 7 (PSMA7) showed especially marked differences between patients with IBD and the healthy controls, in that its expression level was much higher in the CD and UC groups. This exosomal protein is related to proteasome activity and inflammatory responses. So we conclude that in this research, salivary exosomal PSMA7 was present at high levels in salivary exosomes from subjects with IBD. It can be a very promising biomarker to release the patients from the pain of colonoscopy.

Keywords

exosomes / inflammatory bowel disease / proteomics / PSMA7

Cite this article

Download citation ▾
Xiaowen Zheng, Feng Chen, Qian Zhang, Yulan Liu, Peng You, Shan Sun, Jiuxiang Lin, Ning Chen. Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease. Protein Cell, 2017, 8(9): 686-695 DOI:10.1007/s13238-017-0413-7

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

AzmiAS, BaoB, SarkarFH (2013) Exosome in cancer development, metastasis and resistance: a comprehensive review.Cancer Metastasis Rev32:623–642

[2]

BachDH, HongJY, ParkHJ, SkLee (2017) The role of exosomes and miRNAs in drug-resistance of cancer cells.Int J Cancer.

[3]

Benito-MartinA, UceroAC, ZubiriI, Posada-AyalaM, Fermandez-FernandezB, Cannata-OrtizP, Sanchez-NinoMD, Ruiz-OrtegaM, EqidoJ, Alvarez-LlamasG (2013) Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine.PLoS ONE8:e72387

[4]

BianZ, LiL, CuiJ, ZhangH, LiuY, ZhangCY, ZenK (2011) Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis.J Pathol225:544–553

[5]

ChanPP, WasingerVC, LeongRW (2016) Current application of proteomics in biomarker discovery for inflammatory bowel disease.World J Gastrointest Pathophysiol7:27–37

[6]

ChoiDS, ParkJO, JangSC, YoonYJ, JungJW, ChoiDY, KimJW, KangJS, ParkJ(2011) Proteomic analysis of microvesicles derived from human colorectal cancer ascites.Proteomics11:2745–2751

[7]

DowellJA, FrostDC, ZhangL, LiL (2008) Comparison of twodimensional fractionation techniques for shotgun proteomics.Anal Chem80:6715–6723

[8]

HonmaK, TakemasaI, MatobaR, YamamotoY, TakeshitaF, MoriM, MondenM, MatsubaraK, OchiyaT (2009) Screening of potential molecular targets for colorectal cancer therapy. Int J Gen Med2:243–257

[9]

HuXT, ChenW, ZhangFB, ShiQL, HuJB, GengSM, HeC (2009) Depletion of the proteasome subunit PSMA7 inhibits colorectal cancer cell tumorigenicity and migration.Oncol Rep22:1247–1252

[10]

LaiRC, YeoRW, TanKH, LimSK (2013) Exosomes for drug delivery- a novel application for the mesenchymal stem cell.Biotechnol Adv31:543–551

[11]

LankaraniKB, SivandzadehGR, HassanpourS (2013) Oral manifestation in inflammatory bowel disease.World J Gastroenterol19:8571–8579

[12]

LauC, KimY, ChiaD, SpielmannN, EiblG, ElashoffD, WeiF, LinYL, MoroA, GroganT (2013) Role of pancreatic cancerderived exosomes in salivary biomarker development.J Biol Chem288:26888–26897

[13]

MinelliA, MagriC, BarbonA, BonviciniC, SegalaM, CongiuC, BignottiS, MilanesiE, TrabucchiL, CattaneN (2015) Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder.Transl Psychiatry5:e687

[14]

RautavaJ, PinnellLJ, VongL, AkseerN, AssaA, ShermanPM (2015) Oral microbiome composition changes in mouse models of colitis.J Gastroenterol Hepatol30:521–527

[15]

RitchieAJ, CrawfordDM, FerqusonDJ, BurthemJ, RobertsDJ (2013) Normal prion proteins is expressed on exosomes isolated from human plasma.Br J Haematol163:678–680

[16]

Romanuik UedaT, LeN, HaileS, YongTM, ThomsonT, VessellaRL, SadarMD (2009) Novel biomarkers for prostate cancer including noncoding transcripts.Am J Pathol176:2264–2276

[17]

RommelAM, JustinWL, HongJ, RichardJS (2009) Isolation of extracellular membranous vesicle for proteomic analysis.Methods Mol Biol528:227–242

[18]

RowlandM, FlemingP, BourkeB (2010) Looking in the mouth for Crohn’s disease.Inflamm Bowel Dis16:332–337

[19]

SimpsonRJ, LimJW, MoritzRL, MathibvanaS (2009) Exosomes: proteomic insights and diagnostic potential.Expert Rev Proteomics6:267–283

[20]

SiravegnaG, MarsoniS, SienaS, BardelliA (2017) Integrating liquid biopsies into the management of cancer.Nat Rev Clin Oncol.

[21]

TandleAT, CalvaniM, UranchimegB, ZahaviD, MelilloG, LibuttiSK (2009) Endothelial monocyte activating polypeptide-II modulates endothelial cell responses by degrading hypoxia-inducible factor-1alpha through interaction with PSMA7, a component of proteasome.Exp Cell Res315:1850–1859

[22]

VelosoFT (2011) Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?World J Gastroenterol17:2702–2707

[23]

VlassovAV, MagdalenoS, SetterquistR, ConradR (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials.Biochim Biophys Acta1820:940–948

[24]

YamadaT, InoshimaY, MatsudaT, IshiguroN (2012) Comparison of methods for isolating exosomes from bovine milk.J Vet Med Sci74:1523–1525

[25]

ZhangJ, ZhouS, ZhangQ, FengS, ChenY, ZhengH, WangX, ZhaoW, ZhangT, ZhouY (2014) Proteomic analysis of RBP4/VITAMIN A in children with cleft lip and/or palate.J Dent Res93:547–552

[26]

ZhengX, ChenF, ZhangJ, ZhangQ, LinJ (2014) Exosome analysis: a promising biomarker system with special attention to saliva.J Membr Biol247:1129–1136

RIGHTS & PERMISSIONS

The Author(s) 2017. This article is an open access publication

AI Summary AI Mindmap
PDF (879KB)

Supplementary files

PAC-0686-17047-ZXW_suppl_1

PAC-0686-17047-ZXW_suppl_2

PAC-0686-17047-ZXW_suppl_3

PAC-0686-17047-ZXW_suppl_4

PAC-0686-17047-ZXW_suppl_5

PAC-0686-17047-ZXW_suppl_6

PAC-0686-17047-ZXW_suppl_7

PAC-0686-17047-ZXW_suppl_8

880

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/